dr. D.J.A. de Groot

d.j.a.de.groot umcg.nl


  1. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

    van der Velden, D. L., Hoes, L. R., van der Wijngaart, H., Henegouwen, J. M. V. B., van Werkhoven, E., Roepman, P., Schilsky, R. L., de Leng, W. W. J., Huitema, A. D. R., Nuijen, B., Nederlof, P. M., van Herpen, C. M. L., de Groot, D. J. A., Devriese, L. A., Hoeben, A., de Jonge, M. J. A., Chalabi, M., Smit, E. F., de Langen, A. J., Mehra, N., Labots, M., Kapiteijn, E., Sleijfer, S., Cuppen, E., Verheul, H. M. W., Gelderblom, H. & Voest, E. E., 3-Oct-2019, In : Nature. 574, p. 127-131 16 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  2. RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer

    van Helden, E. J., Angus, L., van Oordt, C. W. M. D. H., Heideman, D. A. M., Boon, E., van Es, S. C., Radema, S. A., van Herpen, C. M. L., de Groot, D. J. A., de Vries, E. G. E., Jansen, M. P. H. M., Sleijfer, S. & Verheul, H. M. W., 30-Sep-2019, In : Molecular oncology. 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. A review of bispecific antibodies and antibody constructs in oncology and clinical challenges

    Suurs, F. V., Lub-de Hooge, M. N., de Vries, E. G. E. & de Groot, D. J. A., Sep-2019, In : Pharmacology & Therapeutics. 201, p. 103-119 17 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (28) »

View graph of relations

ID: 230893